These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3952014

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapy of infections caused by 'atypical' mycobacteria.
    Grange JM.
    J Antimicrob Chemother; 1984 Apr; 13(4):308-10. PubMed ID: 6725182
    [No Abstract] [Full Text] [Related]

  • 3. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
    Masur H, Tuazon C, Gill V, Grimes G, Baird B, Fauci AS, Lane HC.
    J Infect Dis; 1987 Jan; 155(1):127-9. PubMed ID: 3794396
    [No Abstract] [Full Text] [Related]

  • 4. Pulmonary infection with nontuberculous mycobacteria.
    Contreras MA, Cheung OT, Sanders DE, Goldstein RS.
    Am Rev Respir Dis; 1988 Jan; 137(1):149-52. PubMed ID: 3337456
    [Abstract] [Full Text] [Related]

  • 5. Environmental mycobacteria. An increasing problem.
    Griffith DE.
    Hosp Pract (Off Ed); 1988 May 15; 23(5):125-30, 132, 137 passim. PubMed ID: 3131352
    [No Abstract] [Full Text] [Related]

  • 6. Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
    Casal M, Rodríguez F, Gutierrez J, Ruiz P, Benavente MC, Villalba R, Moreno G.
    J Chemother; 1989 Feb 15; 1(1):39-45. PubMed ID: 2498468
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
    Murray MP, Laurenson IF, Hill AT.
    Clin Infect Dis; 2008 Jul 15; 47(2):222-4. PubMed ID: 18532890
    [Abstract] [Full Text] [Related]

  • 8. The other mycobacteria.
    Davidson PT.
    Chest; 1979 Feb 15; 75(2):110-1. PubMed ID: 421541
    [No Abstract] [Full Text] [Related]

  • 9. Disseminated Mycobacterium chelonei infection: response to sulfonamides.
    Tice AD, Solomon RJ.
    Am Rev Respir Dis; 1979 Jul 15; 120(1):197-201. PubMed ID: 464378
    [Abstract] [Full Text] [Related]

  • 10. Dynamic aspects of the in vitro chemotherapeutic activity of ansamycin (rifabutine) on mycobacterium intracellulare.
    Perumal VK, Gangadharam PR, Heifets LB, Iseman MD.
    Am Rev Respir Dis; 1985 Dec 15; 132(6):1278-80. PubMed ID: 4073667
    [Abstract] [Full Text] [Related]

  • 11. [Problems of the disease due to mycobacteria other than tubercle bacilli: chemotherapy--with special emphasis on the disease due to M. intracellulare (author's transl)].
    Kita N.
    Kekkaku; 1979 Nov 15; 54(11):543-6. PubMed ID: 522351
    [No Abstract] [Full Text] [Related]

  • 12. Osteomyelitis, pericarditis, mediastinitis, and vasculitis due to mycobacterium chelonei.
    Jauregui L, Arbulu A, Wilson F.
    Am Rev Respir Dis; 1977 Apr 15; 115(4):699-703. PubMed ID: 848795
    [No Abstract] [Full Text] [Related]

  • 13. THE PATHOGENIC "ATYPICAL" MYCOBACTERIA.
    YOUMANS GP.
    Annu Rev Microbiol; 1963 Apr 15; 17():473-94. PubMed ID: 14145309
    [No Abstract] [Full Text] [Related]

  • 14. Mycobacterium conceptionense Pneumonitis in Patient with HIV/AIDS1.
    Michienzi SM, Burgos RM, Novak RM.
    Emerg Infect Dis; 2019 Oct 15; 25(10):1986-1988. PubMed ID: 31538928
    [Abstract] [Full Text] [Related]

  • 15. Methods for determining the antimicrobial susceptibility of mycobacteria.
    Alcaide F, Esteban J, González-Martin J, Palacios JJ.
    Enferm Infecc Microbiol Clin; 2017 Oct 15; 35(8):529-535. PubMed ID: 27236235
    [Abstract] [Full Text] [Related]

  • 16. Microbial substitution of Mycobacterium avium-intracellulare to Mycobacterium abscessus during clinical course.
    Nei T, Saitoh T, Morimoto K, Watanabe K, Hayashihara K, Azuma A, Kudoh S.
    J Infect Chemother; 2007 Oct 15; 13(5):343-5. PubMed ID: 17982725
    [Abstract] [Full Text] [Related]

  • 17. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)].
    Kuze F, Lee Y, Maekawa N, Suzuki Y.
    Kekkaku; 1979 Sep 15; 54(9):453-60. PubMed ID: 502152
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs.
    Kuze F, Kurasawa T, Bando K, Lee Y, Maekawa N.
    Rev Infect Dis; 1981 Sep 15; 3(5):885-97. PubMed ID: 7339820
    [Abstract] [Full Text] [Related]

  • 19. New insights in the treatment of nontuberculous mycobacterial pulmonary disease.
    Ruth MM, van Ingen J.
    Future Microbiol; 2017 Oct 15; 12():1109-1112. PubMed ID: 28972416
    [No Abstract] [Full Text] [Related]

  • 20. ATYPICAL MYCOBACTERIA IN WESTERN AUSTRALIA.
    CARRUTHERS KJ, EDWARDS FG.
    Am Rev Respir Dis; 1965 Jun 15; 91():887-95. PubMed ID: 14294712
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.